InvestorsHub Logo
Followers 4
Posts 153
Boards Moderated 0
Alias Born 10/12/2012

Re: gemmill post# 10352

Thursday, 03/27/2014 6:27:32 PM

Thursday, March 27, 2014 6:27:32 PM

Post# of 48316
Just to follow up from my perspective, I was never concerned one way or the other with a PR, I could not care less about that. The entire discussion arose from the point that when we look at the facts surrounding ASGCT it tells us MCC went to ASCO. If that is the case, that would mean the MCC data was quite significant, which would mean that Orphan Designation and Approval for ImmunoPulse MCC would be very likely.

Not trying to beat a dead horse here, but when we put all this together we get some fairly clear answers as to what is coming. This is in no way definitive, but IMO, we have enough to go on to believe MCC will come out at ASCO (if accepted) and the fact that they would have sent MCC to ASCO in the first place speaks volumes. This is the kind of thing a savvy investor looks for to find out what is coming before official info is released.